Ignite Creation Date:
2024-05-06 @ 7:18 AM
Last Modification Date:
2024-10-26 @ 11:47 AM
Study NCT ID:
NCT02515292
Status:
UNKNOWN
Last Update Posted:
2015-08-06
First Post:
2015-07-29
Brief Title:
Evaluation of Infants With Intrauterine Growth Restriction
Sponsor:
Iuliu Hatieganu University of Medicine and Pharmacy
Organization:
Iuliu Hatieganu University of Medicine and Pharmacy
Study Overview
Official Title:
Multidimensional Modeling in Evaluation of Infants With Intrauterine Growth Restriction
Status:
UNKNOWN
Status Verified Date:
2015-08
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ModeInfIUGR
Brief Summary:
Purpose Clinical assessment anthropometric and paraclinical biochemical and immunological by dosing serum insuline growth factors IGF1 and IGF2 and their receptors of neonates with intrauterine growth restriction IUGR and the integration in a multidimensional statistical model
Objectives
1 IGF1 and IGF2 evaluation of serum and IGF1 receptor IGF2 receptor and IGF2 receptor gene expression in cord blood from newborns with intrauterine growth restriction IUGR Prospective
2 Evaluation and monitoring of anthropometric clinical non-cardiac morbidity and paraclinical Retrospective prospective
3 Evaluation and monitoring of morphological and functional by echocardiography Prospective
4 Integrating multidimensional clinical and paraclinical parameters in a statistical model for evaluating newborn with intrauterine growth restriction
Objectives
1 IGF1 and IGF2 evaluation of serum and IGF1 receptor IGF2 receptor and IGF2 receptor gene expression in cord blood from newborns with intrauterine growth restriction IUGR Prospective
2 Evaluation and monitoring of anthropometric clinical non-cardiac morbidity and paraclinical Retrospective prospective
3 Evaluation and monitoring of morphological and functional by echocardiography Prospective
4 Integrating multidimensional clinical and paraclinical parameters in a statistical model for evaluating newborn with intrauterine growth restriction
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None